Medtronic CEO Omar Ishrak is facing many questions about his plans for the medical-device maker—principally revolving around the deal announced in June to buy Irish medical supplier Covidien and move the company's headquarters to Dublin from Minneapolis.
Ishrak answered a few of these questions for us this week in a phone interview recorded for a podcast and a Q&A to appear soon in the print edition of Modern Healthcare. Here are some highlights previewing the full interview.
Medtronic's migration would join a wave of tax inversion deals raising concern in Washington. This month, Treasury Secretary Jacob Lew asked Congress to consider legislation that would make it more difficult for companies to limit their U.S. tax liability by expatriating their corporate headquarters.